arGEN-X BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 5 PAGES: 25

More Info
									             arGEN-X BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH140762D                                                                                                          Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      arGEN-X BV (arGEN-X) is a Pharmaceuticals and Healthcare company, based in
                                                                                                              arGEN-X BV, Pharmaceuticals & Healthcare, Key
      the Netherlands. The company operates through Drug Discovery and
                                                                                                              Facts
      manufacturing, Research and Development (R&D), and Biotechnology. Its products
      include ARGX-109, ARGX-110 and ARGX-111. The company discovers and                                       Web Address                        www.argen-x.com
      develops novel, antibody therapeutics for making patients life better. The
                                                                                                               Revenue (US$ million)                           NA
      productivity portfolio of novel preclinical programs provides oncology, autoimmune
      and inflammation indications. It has developed an antibody pipeline during the BIO-                      Number of Employees                             NA
      Europe Spring event in Barcelona. The company has an alliance with Eli Lilly and                         GlobalData
      Company (“Lilly”), and shire. It was incorporated in the year, 2008.

      Financial Deals Landscape
        arGEN-X BV, Pharmaceuticals & Healthcare, Deals by Type, 2007                     arGEN-X BV, Pharmaceuticals & Healthcare, Deals By Year,
        to YTD 2013                                                                       2007 to YTD 2013


                                                                                                                                                  3
                                                                                                          3




                                                                                           No. of Deals
                                                                                                                                                         2
                                                                                                          2

                                                                                                                                 1                                1
                                                                                                          1

                                                                                                                 0      0               0
                                                                                                          0
                                                                                                               2007    2008   2009     2010      2011   2012     YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         arGEN-X BV, Pharmaceuticals & Healthcare, Deals By                               arGEN-X BV, Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         8     7                                                                          6
                                                                                                                        5
          No. of Deals




                         6                                                                                5
                                                                                           No. of Deals




                         4              3                                                                 4

                         2                       1         1         1                                    3
                                                                                                                                        2                2
                         0                                                                                2
                             Europe   North     Asia-    Middle   South                                   1
                                      Americ   Pacific    East     and
                                        a                 and     Central                                 0
                                                         Africa   Americ                                             Immunolog        Genetic         Oncology
                                                                    a                                                    y           Disorders


         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




arGEN-X BV - Pharmaceuticals & Healthcare - Deals and Alliances                                                                               Reference Code: GDPH140762D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                               Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       arGEN-X BV, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................................. 4
       arGEN-X BV, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .............................................................................. 5
       arGEN-X BV, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ......................................................................... 6
       arGEN-X BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................................... 7
       arGEN-X BV, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013........................................................................... 8
       arGEN-X BV, Pharmaceuticals & Healthcare, Deal Details ................................................................................................................ 9
          Venture Financing........................................................................................................................................................................... 9
             arGEN-X Secures $37 Million In Series B Financing Round ....................................................................................................... 9
             arGEN-X Raises Additional $4.5 Million In Series A Financing Round ..................................................................................... 12
          Partnerships.................................................................................................................................................................................. 14
             Argen-X Expands Co-Development Agreement With Shire For Additional Therapeutic Antibody............................................. 14
             arGEN-X Enters Into Co-Development Agreement With Shire For Therapeutic Antibody......................................................... 15
          Licensing Agreements .................................................................................................................................................................. 17
             RuiYi Enters Into Licensing Agreement With arGEN-X For ARGX-109..................................................................................... 17
             arGEN-X Enters Into Licensing Agreement With Biowa ............................................................................................................ 18
             arGEN-X Enters Into Licensing Agreement With Eli Lilly........................................................................................................... 19
       arGEN-X BV - Key Competitors ....................................................................................................................................................... 20
       Key Employees ................................................................................................................................................................................ 21
       Locations And Subsidiaries .............................................................................................................................................................. 22
          Head Office ................................................................................................................................................................................... 22
          Other Locations & Subsidiaries ..................................................................................................................................................... 22
       Recent Developments ...................................................................................................................................................................... 23
          Corporate Communications .......................................................................................................................................................... 23
             Mar 19, 2012: arGEN-X Announces Senior Management Changes .................................................
								
To top